Aug. 25, 2026 — Radiology Partners has entered into a definitive agreement to acquire Everlight Radiology, an international teleradiology provider serving hospitals, health systems and imaging centers across the United Kingdom, Ireland, Australia, New Zealand and South Africa. The transaction is subject to customary regulatory approvals and closing conditions.

August 18, 2026 – NewVue, a provider of cloud-native software that unifies how radiologists work while improving practice efficiency, has partnered with Strategic Radiology, a coalition of 50 independent, radiologist-owned practices representing more than 2,500 radiologists nationwide.

Aug. 20, 2026 — Candelis, Inc. has announced a collaboration with GE HealthCare to support the distribution of Candelis ImageGrid StreamVue for viewing images generated by the GE HealthCare Invenia Automated Breast Ultrasound (ABUS) systems.

The collaboration brings together GE HealthCare's breast ultrasound technology and Candelis' enterprise imaging and diagnostic viewing expertise to support remote review of Invenia ABUS studies across enterprise imaging environments.

Aug. 18, 2026 —The board of trustees of the Radiological Society of North America's (RSNA) Research & Education (R&E) Foundation has approved more than $4.5 million in grants this year to support investigators and educators addressing critical challenges in medical imaging and radiation oncology.

Aug. 20, 2026 — Subtle Medical has appointed Lawrence N. Tanenbaum, MD, FACR, as Executive Medical Director and Chair of the company's Medical Advisory Board. A nationally recognized neuroradiologist, technology leader and pioneer in the adoption of artificial intelligence in radiology, Tanenbaum brings decades of experience translating emerging imaging technologies into real-world clinical practice.

Aug. 13, 2026 — Epic's new Care Everywhere Diagnostic Image Exchange allows health systems using Epic to share diagnostic-quality images including CTs, X-rays, MRIs and more — so clinicians get the image they need to reach a diagnosis faster, and patients can start treatment sooner.

Aug. 20, 2026 – The novel, radiopaque, polymer-based embolic coil from Embolization, Inc. has now surpassed 125 implants nationwide, demonstrating continued success.

Aug. 14, 2026 —  Lantheus Holdings recently announced U.S. Food and Drug Administration (FDA) approval of Tauklarify (florquinitau F 18 injection), also referred to as MK-6240, a radiodiagnostic agent indicated for positron emission tomography (PET) of the brain in adults with cognitive impairment who are being evaluated for Alzheimer’s disease to identify patients with tau neurofibrillary tangle (NFT) pathology. Tauklarify has a limitation of use.

Aug. 13, 2026 — The Focused Ultrasound Foundation and Bracco Imaging have announced a partnership to facilitate access to Bracco’s research version of the SonoVue microbubble (so-called BR1), helping accelerate preclinical focused ultrasound research worldwide.

Microbubble-assisted focused ultrasound techniques have the potential to improve treatments for neurodegenerative diseases, brain tumors, mental health disorders and solid tumors throughout the body.

Aug. 18, 2026 — Cortech.AI's NeuroQuant PET has received FDA 510(k) clearance (K261916) for PET. NeuroQuant PET aids physicians in the evaluation of patient pathologies and the clinical interpretation of PET performed for the assessment of cognitive impairment and other neurological conditions.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now